Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Elif Sargin Altunok"'
Autor:
Celal Satici, Mustafa Asim Demirkol, Elif Sargin Altunok, Bengul Gursoy, Mustafa Alkan, Sadettin Kamat, Berna Demirok, Cemile Dilsah Surmeli, Mustafa Calik, Zuhal Cavus, Sinem Nihal Esatoglu
Publikováno v:
International Journal of Infectious Diseases, Vol 98, Iss , Pp 84-89 (2020)
Objective: The aim of the study was to analyze the usefulness of CURB-65 and the pneumonia severity index (PSI) in predicting 30-day mortality in patients with COVID-19, and to identify other factors associated with higher mortality. Methods: A retro
Externí odkaz:
https://doaj.org/article/2ff1a8b77ddf4221ac817b7142614116
Publikováno v:
Mediterranean Journal of Infection, Microbes and Antimicrobials, Vol 10, Iss 1 (2021)
Candida auris is a rapidly emerging fungus, which is considered globally a cause of concern for public health. This report describes Turkey’s second case of Candida auris fungemia from a tertiary care hospital in İstanbul. An 18-year-old male pati
Externí odkaz:
https://doaj.org/article/de00e75245814e5fb60f643b8221e196
Autor:
Elif Sargin Altunok, Murat Sayan, Sila Akhan, Bilgehan Aygen, Orhan Yildiz, Suda Tekin Koruk, Resit Mistik, Nese Demirturk, Onur Ural, Şükran Kose, Aynur Aynioglu, Fatime Korkmaz, Gülden Ersoz, Nazan Tuna, Celal Ayaz, Faruk Karakecili, Derya Keten, Dilara Inan, Saadet Yazici, Safiye Koculu, Taner Yildirmak
Publikováno v:
International Journal of Infectious Diseases, Vol 50, Iss C, Pp 1-5 (2016)
Background: Drug resistance development is an expected problem during treatment with protease inhibitors (PIs), this is largely due to the fact that Pls are low-genetic barrier drugs. Resistance-associated variants (RAVs) however may also occur natur
Externí odkaz:
https://doaj.org/article/746674f3f2674d80aa0bd064e45cced1
Autor:
Muhammed Emin Kostek, Sinem Nihal Esatoglu, Elif Sargin Altunok, Semih Yazla, İlkim Deniz Toprak, Mustafa Asim Demirkol, Mustafa Alkan, Celal Satici, Sadettin Kamat, Veysel Dinc
Publikováno v:
Journal of Medical Virology
Due to current advances and growing experience in the management of coronavirus Disease 2019 (COVID‐19), the outcome of COVID‐19 patients with severe/critical illness would be expected to be better in the second wave compared with the first wave.
Autor:
Elif Sargin Altunok, Mustafa Asim Demirkol, Sinem Nihal Esatoglu, Celal Satici, Ferhat Cengel, Okan Gurkan
Publikováno v:
Clinical Imaging
Purpose There is scarce data on the impact of the presence of mediastinal lymphadenopathy on the prognosis of coronavirus-disease 2019 (COVID-19). We aimed to investigate whether its presence is associated with increased risk for 30-day mortality in
Autor:
Celal Satici, Cemile Dilsah Surmeli, Akaberk Börü, Bengul Gursoy, Berna Demirok, Mustafa Asim Demirkol, Mustafa Alkan, Sadettin Kamat, Elif Sargin Altunok
Publikováno v:
Journal of Medical Virology
In this study, laboratorial parameters of hospitalized novel coronavirus (COVID‐19) patients, who were complicated with severe pneumonia, were compared with the findings of cytokine storm developing in macrophage activation syndrome (MAS)/secondary
Publikováno v:
Viral Hepatitis Journal. 26:141-150
Autor:
Mustafa Asim Demirkol, Sebahat Nacar Dogan, Elif Sargin Altunok, Mustafa Calik, Ferhat Cengel, Okan Gurkan, Mehmet Fatih Kaya
Publikováno v:
Hong Kong Journal of Emergency Medicine. 28:15-21
Background: Effective triage and early detection are very important for the control and treatment of coronavirus disease 2019. For this purpose, reverse transcription polymerase chain reaction and chest computed tomography are used in emergency depar
Autor:
Zuhal Cavus, Cemile Dilsah Surmeli, Bengul Gursoy, Celal Satici, Elif Sargin Altunok, Mustafa Asim Demirkol, Mustafa Alkan, Mustafa Calik, Berna Demirok, Sadettin Kamat, Sinem Nihal Esatoglu
Publikováno v:
International Journal of Infectious Diseases, Vol 98, Iss, Pp 84-89 (2020)
International Journal of Infectious Diseases
International Journal of Infectious Diseases
Highlights • The CURB-65 scores and pneumonia severity index (PSI) are widely used to predict mortality in patients with community acquired pneumonia. • There is no scoring system to predict mortality in patients with COVID-19. • The PSI scores
Publikováno v:
Journal of the College of Physicians and Surgeons Pakistan. 30:43-45
Coronavirus disease (COVID-19), first reported in December 2019 in Wuhan, China, has spread all over the world in a short time and was declared as a pandemic by the World Health Organization (WHO). During COVID-19 pandemic, chest computed tomography